Baudax Bio (NASDAQ:BXRX) reported its Q2 earnings results on Thursday, August 11, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Baudax Bio beat estimated earnings by 45.67%, reporting an EPS of $-0.69 versus an estimate of $-1.27.

Revenue was up $99 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $1.4 which was followed by a 17.24% drop in the share price the next day.

Here's a look at Baudax Bio's past performance:

To track all earnings releases for Baudax Bio visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.